-
Signature
-
/s/ Marc Rosenbaum, attorney-in-fact
-
Issuer symbol
-
IRTC
-
Transactions as of
-
31 Oct 2025
-
Net transactions value
-
-$1,659,520
-
Form type
-
4
-
Filing time
-
03 Nov 2025, 16:30:36 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Wilson Daniel G. |
Chief Financial Officer |
C/O IRHYTHM TECHNOLOGIES, INC., 699 8TH ST #600, SAN FRANCISCO |
/s/ Marc Rosenbaum, attorney-in-fact |
03 Nov 2025 |
0001860745 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
IRTC |
Common Stock |
Sale |
$1,659,520 |
-8,000 |
-23% |
$207.44 |
26,470 |
31 Oct 2025 |
Direct |
F1 |
| holding |
IRTC |
Common Stock |
|
|
|
|
|
100 |
31 Oct 2025 |
Held through a Family Trust |
F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: